INNOVATIVE HEALTH TECHNOLOGY
At MellingMedical, we recognize and appreciate the advanced technological solutions offered by Xtrava, a company initially recognized for its significant contributions during the pandemic through their rapid antigen testing platform. Since then, Xtrava has pivoted their focus onto more technologically advanced solutions, such as their portable digital reader and smartphone-compatible app for improved diagnostic sensitivity and disease tracking.
Xtrava is currently embracing a technology licensing model, offering their lateral flow readers and digital platforms to other manufacturers. This strategic shift empowers Xtrava to extend their impact in the realm of general surgery through digital integration, supporting more precise and accessible diagnostic processes. By focusing on a pandemic preparedness platform, the company addresses the evolving needs of healthcare systems, including federal facilities serving veterans and others, by enabling better preparedness and response tools for future healthcare challenges.
STRUCTURED FEDERAL PROCUREMENT
Through MellingMedical’s structured procurement pathways established to facilitate the availability of innovative healthcare technology for federal healthcare systems, companies like Xtrava are able to assist veterans and other patients within these systems with access to the necessary tools and technology. This is particularly important where digital health and testing technology are concerned, as these tools can significantly enhance the service capabilities of healthcare facilities.
Our approach enables federal healthcare systems to seamlessly integrate advanced solutions like those offered by Xtrava, ensuring that procurement processes are both compliant and efficient. This not only supports the operational effectiveness of these systems but also helps to meet their unique healthcare needs without compromising on the quality or efficacy of the technologies employed.